These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2991692)

  • 1. In ability of Na+,K+-ATPase inhibitor to cause hypertension in sodium-loaded or deoxycorticosterone-treated one kidney rats.
    Nirasawa Y; Temma K; Fink GD; Akera T
    Life Sci; 1985 Aug; 37(8):767-74. PubMed ID: 2991692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of Na+-K+ ATPase activity on blood pressure regulation and sodium metabolism in DOCA-treated rats].
    Shigetomi S; Tosaki H; Ueno S; Kohno H; Mori K; Katoh K; Tanaka K; Haga H; Kin S; Matsunaga A
    Nihon Naibunpi Gakkai Zasshi; 1989 Oct; 65(10):1198-207. PubMed ID: 2556303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of high calcium diet on arterial smooth muscle function and electrolyte balance in mineralocorticoid-salt hypertensive rats.
    Arvola P; Ruskoaho H; Pörsti I
    Br J Pharmacol; 1993 Apr; 108(4):948-58. PubMed ID: 8485634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (Na+ -K+)ATPase activity in erythrocyte membranes of spontaneously, one kidney-one wrapped, and deoxycorticosterone acetate--NaCl hypertensive rats.
    Chen CC; Lin-Shiau SY
    Biochem Pharmacol; 1988 May; 37(9):1661-6. PubMed ID: 2837236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium-potassium ATPase in deoxycorticosterone-salt hypertension: opposing effects of sodium load and mineralocorticoids.
    Stern N; Beck FW; Vlachakis N; Eggena P; Sowers JR
    Endocrinology; 1984 Feb; 114(2):624-8. PubMed ID: 6317363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension.
    Ferrari P; Ferrandi M; Tripodi G; Torielli L; Padoani G; Minotti E; Melloni P; Bianchi G
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1074-83. PubMed ID: 10027844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular sodium pump activity kinetics in early and advanced stages of deoxycorticosterone-salt hypertension in rats.
    Songu-Mize E
    Life Sci; 1991; 49(26):2045-52. PubMed ID: 1660956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Droy-Lefaix MT; Lakatta EG; Bagrov AY
    Hypertension; 2003 Mar; 41(3):505-11. PubMed ID: 12623951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two brain inhibitors inhibit renal Na,K-ATPases without recognizing the species-dependent variation of their ouabain-sensitivity.
    Anner BM
    Clin Exp Hypertens; 1998; 20(5-6):489-97. PubMed ID: 9682905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.
    Pamnani MB; Swindall BT; Schooley JF; Ghai R; Haddy FJ
    Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):115-21. PubMed ID: 10099845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ouabain-like factors in hypertension: effects of ouabain and certain endogenous ouabain-like factors in hypertension.
    Yuan C; Manunta P; Chen S; Hamlyn JM; Haddy FJ; Pamnani MB
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S10-2. PubMed ID: 7508010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor.
    Fedorova OV; Zhuravin IA; Agalakova NI; Yamova LA; Talan MI; Lakatta EG; Bagrov AY
    J Hypertens; 2007 Sep; 25(9):1834-44. PubMed ID: 17762648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Affinity chromatographic study of the changes in the endogenous Na+-K+-ATPase inhibitor during sodium loading in man].
    Cloix JF; Henning G; Crabos M; Delva P; Meyer P
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1251-5. PubMed ID: 6098236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of chloride in deoxycorticosterone hypertension: selective sodium loading by diet or drinking fluid.
    Kunes J; Zicha J; Jelínek J
    Physiol Res; 2004; 53(2):149-54. PubMed ID: 15046550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of Dahl rats.
    Fedorova OV; Lakatta EG; Bagrov AY
    Circulation; 2000 Dec; 102(24):3009-14. PubMed ID: 11113054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial Na+-K+-ATPase activity and [3H]ouabain binding sites in hypertensive rats.
    Chen CC; Shiau SY
    Eur J Pharmacol; 1989 Oct; 169(1):67-74. PubMed ID: 2557224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of salt intake and of (Na+K)-ATPase activity in brain after high dose treatment with deoxycorticosterone.
    Grillo C; Coirini H; McEwen BS; De Nicola AF
    Brain Res; 1989 Oct; 499(2):225-33. PubMed ID: 2553208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrophotometric assay of renal ouabain-resistant Na(+)-ATPase and its regulation by leptin and dietary-induced obesity.
    Bełtowski J; Jamroz-Wiśniewska A; Nazar J; Wójcicka G
    Acta Biochim Pol; 2004; 51(4):1003-14. PubMed ID: 15625572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hypertension induced by ouabain but not digoxin in the rat: antihypertensive effect of digoxin and digitoxin.
    Manunta P; Hamilton J; Rogowski AC; Hamilton BP; Hamlyn JM
    Hypertens Res; 2000 Sep; 23 Suppl():S77-85. PubMed ID: 11016824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and identification of hemin as an endogenous Na+/K(+)-ATPase inhibitor from porcine blood cells.
    Yasuhara T; Mori M; Wakamatsu K; Kubo K
    Biochem Biophys Res Commun; 1991 Jul; 178(1):95-103. PubMed ID: 1648917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.